Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nouara Yahi

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Cancer Letters|February 14, 2009
The first extracellular domain of the tumour stem cell marker CD133 contains an antigenic ganglioside-binding motifNadira Taïeb, Marc Maresca, Xiao-Jun Guo, et al.
Toxicology and Applied Pharmacology|March 1, 2008
Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: stimulation of interleukin-8 secretion, potentiation of interleukin-1beta effect and increase in the transepithelial passage of commensal bacteriaMarc Maresca, Nouara Yahi, Lama Younès-Sakr, et al.
Pharmacology & Therapeutics|January 19, 2025
Conformationally adaptive therapeutic peptides for diseases caused by intrinsically disordered proteins (IDPs). New paradigm for drug discovery: Target the target, not the arrowJacques Fantini, Fodil Azzaz, Coralie Di Scala, et al.
Journal of Molecular Biology|February 2, 2010
Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosidesEric Di Pasquale, Jacques Fantini, Henri Chahinian, et al.
Journal of Medical Virology|January 8, 2022
The puzzling mutational landscape of the SARS-2-variant OmicronJacques Fantini, Nouara Yahi, Philippe Colson, et al.
Frontiers in Bioscience (Landmark Edition)|September 4, 2023
Structure of the Myelin Sheath Proteolipid Plasmolipin (PLLP) in a Ganglioside-Containing Lipid RaftFodil Azzaz, Morgane Mazzarino, Henri Chahinian, et al.
ACS Chemical Neuroscience|March 21, 2013
Biochemical identification of a linear cholesterol-binding domain within Alzheimer's β amyloid peptideCoralie Di Scala, Nouara Yahi, Clément Lelièvre, et al.
Biochimica Et Biophysica Acta|December 15, 2015
Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosidesCoralie Di Scala, Nouara Yahi, Alessandra Flores, et al.
Scientific Reports|June 30, 2016
Common molecular mechanism of amyloid pore formation by Alzheimer's β-amyloid peptide and α-synucleinCoralie Di Scala, Nouara Yahi, Sonia Boutemeur, et al.
International Journal of Molecular Sciences|November 13, 2021
Gene Therapy Strategy for Alzheimer's and Parkinson's Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y CellsAssou El-Battari, Léa Rodriguez, Henri Chahinian, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Cancer Letters|February 14, 2009
The first extracellular domain of the tumour stem cell marker CD133 contains an antigenic ganglioside-binding motifNadira Taïeb, Marc Maresca, Xiao-Jun Guo, et al.
Toxicology and Applied Pharmacology|March 1, 2008
Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: stimulation of interleukin-8 secretion, potentiation of interleukin-1beta effect and increase in the transepithelial passage of commensal bacteriaMarc Maresca, Nouara Yahi, Lama Younès-Sakr, et al.
Pharmacology & Therapeutics|January 19, 2025
Conformationally adaptive therapeutic peptides for diseases caused by intrinsically disordered proteins (IDPs). New paradigm for drug discovery: Target the target, not the arrowJacques Fantini, Fodil Azzaz, Coralie Di Scala, et al.
Journal of Molecular Biology|February 2, 2010
Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosidesEric Di Pasquale, Jacques Fantini, Henri Chahinian, et al.
Journal of Medical Virology|January 8, 2022
The puzzling mutational landscape of the SARS-2-variant OmicronJacques Fantini, Nouara Yahi, Philippe Colson, et al.
Frontiers in Bioscience (Landmark Edition)|September 4, 2023
Structure of the Myelin Sheath Proteolipid Plasmolipin (PLLP) in a Ganglioside-Containing Lipid RaftFodil Azzaz, Morgane Mazzarino, Henri Chahinian, et al.
ACS Chemical Neuroscience|March 21, 2013
Biochemical identification of a linear cholesterol-binding domain within Alzheimer's β amyloid peptideCoralie Di Scala, Nouara Yahi, Clément Lelièvre, et al.
Biochimica Et Biophysica Acta|December 15, 2015
Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosidesCoralie Di Scala, Nouara Yahi, Alessandra Flores, et al.
Scientific Reports|June 30, 2016
Common molecular mechanism of amyloid pore formation by Alzheimer's β-amyloid peptide and α-synucleinCoralie Di Scala, Nouara Yahi, Sonia Boutemeur, et al.
International Journal of Molecular Sciences|November 13, 2021
Gene Therapy Strategy for Alzheimer's and Parkinson's Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y CellsAssou El-Battari, Léa Rodriguez, Henri Chahinian, et al.
Pageof 7